QFCUH picture
FRNLEN

>>Overview of scientific publications : Prof. Alice FERSTER

Alice FERSTER

1: Veiga-da-Cunha M, Chevalier N, Stephenne X, Defour JP, Paczia N, Ferster A, Achouri Y, Dewulf JP, Linster CL, Bommer GT, Van Schaftingen E. Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency. Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1241-1250. doi: 10.1073/pnas.1816143116. Epub 2019 Jan 9.
>PubMed

2: Dedeken L, Lê PQ, Rozen L, El Kenz H, Huybrechts S, Devalck C, Diallo S, Heijmans C, Ferster A. Automated RBC exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload. Transfusion. 2018 Jun;58(6):1356-1362. doi: 10.1111/trf.14575. Epub 2018 Mar 25.
>PubMed

3: Rodriguez A, Duez P, Dedeken L, Cotton F, Ferster A. Hydroxyurea (hydroxycarbamide) genotoxicity in pediatric patients with sickle cell disease. Pediatr Blood Cancer. 2018 Jul;65(7):e27022. doi: 10.1002/pbc.27022. Epub 2018 Mar 7.
>PubMed

4: Lesport E, Ferster A, Biver A, Roch B, Vasquez N, Jabado N, Vives FL, Revy P, Soulier J, de Villartay JP. Reduced recruitment of 53BP1 during interstrand crosslink repair is associated with genetically inherited attenuation of mitomycin C sensitivity in a family with Fanconi anemia. Oncotarget. 2017 Dec 17;9(3):3779-3793. doi: 10.18632/oncotarget.23375. eCollection 2018 Jan 9.
>PubMed

5: Blumental S, Ferster A, Azzi N, Lepage P. [Management of vaccination in children receiving an allogeneic marrow transplant]. Rev Med Brux. 2017;38(5):427-438. French.
>PubMed

6: Piette C, Suciu S, Clappier E, Bertrand Y, Drunat S, Girard S, Yakouben K, Plat G, Dastugue N, Mazingue F, Grardel N, van Roy N, Uyttebroeck A, Costa V, Minckes O, Sirvent N, Simon P, Lutz P, Ferster A, Pluchart C, Poirée M, Freycon C, Dresse MF, Millot F, Chantrain C, van der Werff Ten Bosch J, Norga K, Gilotay C, Rohrlich PS, Benoit Y, Cavé H. Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials. Leukemia. 2018 Jan;32(1):244-248. doi: 10.1038/leu.2017.289. Epub 2017 Sep 19.
>PubMed

7: Mondelaers V, Suciu S, De Moerloose B, Ferster A, Mazingue F, Plat G, Yakouben K, Uyttebroeck A, Lutz P, Costa V, Sirvent N, Plouvier E, Munzer M, Poirée M, Minckes O, Millot F, Plantaz D, Maes P, Hoyoux C, Cavé H, Rohrlich P, Bertrand Y, Benoit Y; Children–s Leukemia Group (CLG) of the European Organization for Research and Treatment of Cancer (EORTC). Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951. Haematologica. 2017 Oct;102(10):1727-1738. doi: 10.3324/haematol.2017.165845. Epub 2017 Jul 27.
>PubMed

8: Lê PQ, Ferster A, Dedeken L, Vermylen C, Vanderfaeillie A, Rozen L, Heijmans C, Huybrechts S, Devalck C, Cotton F, Ketelslegers O, Dresse MF, Fils JF, Gulbis B. Neonatal screening improves sickle cell disease clinical outcome in Belgium. J Med Screen. 2018 Jun;25(2):57-63. doi: 10.1177/0969141317701166. Epub 2017 Jul 7.
>PubMed

9: Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Pinto Simões B, Ferster A, Dupont S, de la Fuente J, Dalle JH, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand Y, Vannier JP, Ayas M, Cavazzana M, Matthes-Martin S, Rocha V, Elayoubi H, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M; Eurocord, the Pediatric Working Party of the European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood. 2017 Mar 16;129(11):1548-1556. doi: 10.1182/blood-2016-10-745711. Epub 2016 Dec 13.
>PubMed

10: Ghazavi F, De Moerloose B, Van Loocke W, Wallaert A, Helsmoortel HH, Ferster A, Bakkus M, Plat G, Delabesse E, Uyttebroeck A, Van Nieuwerburgh F, Deforce D, Van Roy N, Speleman F, Benoit Y, Lammens T, Van Vlierberghe P. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia. Oncotarget. 2016 Nov 8;7(45):73769-73780. doi: 10.18632/oncotarget.12063.
>PubMed

11: Rozen L, Noubouossie D, Dedeken L, Huybrechts S, Lê PQ, Ferster A, Demulder A. Different profile of thrombin generation in children with acute lymphoblastic leukaemia treated with native or pegylated asparaginase: A cohort study. Pediatr Blood Cancer. 2017 Feb;64(2):294-301. doi: 10.1002/pbc.26228. Epub 2016 Sep 8.
>PubMed

12: Debaugnies F, Mahadeb B, Ferster A, Meuleman N, Rozen L, Demulder A, Corazza F. Performances of the H-Score for Diagnosis of Hemophagocytic Lymphohistiocytosis in Adult and Pediatric Patients. Am J Clin Pathol. 2016 Jun;145(6):862-70. doi: 10.1093/ajcp/aqw076. Epub 2016 Jun 12.
>PubMed

13: Cavé H, Caye A, Strullu M, Aladjidi N, Vignal C, Ferster A, Méchinaud F, Domenech C, Pierri F, Contet A, Cacheux V, Irving J, Kratz C, Clavel J, Verloes A. Acute lymphoblastic leukemia in the context of RASopathies. Eur J Med Genet. 2016 Mar;59(3):173-8. doi: 10.1016/j.ejmg.2016.01.003. Epub 2016 Feb 5.
>PubMed

14: De Laet C, Laeremans H, Ferster A, Gulbis B, Mansbach AL, Jonniaux E, Regal L, Goyens P. [Newborn screening : the point of view of the paediatrician]. Rev Med Brux. 2015 Sep;36(4):212-8. Review. French.
>PubMed

15: Simon P, Suciu S, Clappier E, Cave H, Sirvent N, Plat G, Thyss A, Mechinaud F, Costa VM, Ferster A, Lutz P, Mazingue F, Plantaz D, Plouvier E, Bertrand Y, Benoit Y, Dastugue N, Rohrlich PS; Children’s Leukemia Group (CLG) of the European Organisation for Research and Treatment of Cancer (EORTC). Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials. Ann Hematol. 2016 Jan;95(1):93-103. doi: 10.1007/s00277-015-2515-8. Epub 2015 Oct 12.
>PubMed

16: Van Saen D, Pino Sánchez J, Ferster A, van der Werff ten Bosch J, Tournaye H, Goossens E. Is the protein expression window during testicular development affected in patients at risk for stem cell loss? Hum Reprod. 2015 Dec;30(12):2859-70. doi: 10.1093/humrep/dev238. Epub 2015 Sep 23.
>PubMed

17: Driessen EM, de Lorenzo P, Campbell M, Felice M, Ferster A, Hann I, Vora A, Hovi L, Escherich G, Li CK, Mann G, Leblanc T, Locatelli F, Biondi A, Rubnitz J, Schrappe M, Silverman L, Stary J, Suppiah R, Szczepanski T, Valsecchi M, Pieters R. Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol. Leukemia. 2016 May;30(5):1184-7. doi: 10.1038/leu.2015.246. Epub 2015 Sep 15. Erratum in: Leukemia. 2017 Dec;31(12 ):2854.
>PubMed

18: Lê PQ, Gulbis B, Dedeken L, Dupont S, Vanderfaeillie A, Heijmans C, Huybrechts S, Devalck C, Efira A, Dresse MF, Rozen L, Benghiat FS, Ferster A. Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. Pediatr Blood Cancer. 2015 Nov;62(11):1956-61. doi: 10.1002/pbc.25608. Epub 2015 Jul 14.
>PubMed

19: Ghazavi F, Clappier E, Lammens T, Suciu S, Caye A, Zegrari S, Bakkus M, Grardel N, Benoit Y, Bertrand Y, Minckes O, Costa V, Ferster A, Mazingue F, Plat G, Plouvier E, Poirée M, Uyttebroeck A, van der Werff-Ten Bosch J, Yakouben K, Helsmoortel H, Meul M, Van Roy N, Philippé J, Speleman F, Cavé H, Van Vlierberghe P, De Moerloose B. CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol. Haematologica. 2015 Oct;100(10):1311-9. doi: 10.3324/haematol.2015.126953. Epub 2015 Jul 2.
>PubMed

20: Demeestere I, Simon P, Dedeken L, Moffa F, Tsépélidis S, Brachet C, Delbaere A, Devreker F, Ferster A. Live birth after autograft of ovarian tissue cryopreserved during childhood. Hum Reprod. 2015 Sep;30(9):2107-9. doi: 10.1093/humrep/dev128. Epub 2015 Jun 9.
>PubMed

21: Clappier E, Grardel N, Bakkus M, Rapion J, De Moerloose B, Kastner P, Caye A, Vivent J, Costa V, Ferster A, Lutz P, Mazingue F, Millot F, Plantaz D, Plat G, Plouvier E, Poirée M, Sirvent N, Uyttebroeck A, Yakouben K, Girard S, Dastugue N, Suciu S, Benoit Y, Bertrand Y, Cavé H; European Organisation for Research and Treatment of Cancer, Children's Leukemia Group (EORTC-CLG). IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951. Leukemia. 2015 Nov;29(11):2154-61. doi: 10.1038/leu.2015.134. Epub 2015 Jun 8.
>PubMed

22: Sauvage D, Roufosse F, Sanoussi I, Massin M, Rooze S, De Ville A, Azzi N, Huybrechts S, Dedeken L, Devalck C, Ferster A. Treatment-refractory hypereosinophilic syndrome responding to fludarabine in a 12-year-old boy. Leuk Lymphoma. 2015;56(9):2711-3. doi: 10.3109/10428194.2014.1003058. Epub 2015 Feb 25.
>PubMed

23: Aloni MN, Lecerf P, Lê PQ, Heijmans C, Huybrechts S, Devalck C, Azzi N, Ngalula-Mujinga M, Ferster A. Is Pica under-reported in children with sickle cell disease? A pilot study in a Belgian cohort. Hematology. 2015 Aug;20(7):429-32. doi: 10.1179/1607845414Y.0000000219. Epub 2014 Dec 10.
>PubMed

24: Dedeken L, Chapusette R, Lê PQ, Heijmans C, Devalck C, Huybrechts S, Ziereisen F, Hanssens L, Rozen L, Noubouossie D, Mujinga MN, Ferster A. Reduction of the six-minute walk distance in children with sickle cell disease is correlated with silent infarct: results from a cross-sectional evaluation in a single center in Belgium. PLoS One. 2014 Oct 2;9(9):e108922. doi: 10.1371/journal.pone.0108922. eCollection 2014.
>PubMed

25: Blumental S, Ferster A, Van den Wijngaert S, Lepage P. HIV transmission through breastfeeding: still possible in developed countries. Pediatrics. 2014 Sep;134(3):e875-9. doi: 10.1542/peds.2013-3022.
>PubMed

26: Aloni MN, Lê PQ, Heijmans C, Huybrechts S, Devalck C, Azzi N, Ngalula-Mujinga M, Ferster A. A pilot study of manual chronic partial exchange transfusion in children with sickle disease. Hematology. 2015 Jun;20(5):284-8. doi: 10.1179/1607845414Y.0000000191. Epub 2014 Aug 18.
>PubMed

27: Neven B, Bruneau J, Stolzenberg MC, Meyts I, Magerus-Chatinet A, Moens L, Lanzarotti N, Weller S, Amiranoff D, Florkin B, Bader-Meunier B, Leverger G, Ferster A, Chantrain C, Blanche S, Picard C, Molina TJ, Brousse N, Durandy A, Rizzi M, Bossuyt X, Fischer A, Rieux-Laucat F. Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients. Blood. 2014 Sep 4;124(10):1597-609. doi: 10.1182/blood-2014-02-553834. Epub 2014 Jun 26.
>PubMed

28: Imbert R, Moffa F, Tsepelidis S, Simon P, Delbaere A, Devreker F, Dechene J, Ferster A, Veys I, Fastrez M, Englert Y, Demeestere I. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis. Hum Reprod. 2014 Sep;29(9):1931-40. doi: 10.1093/humrep/deu158. Epub 2014 Jun 22.
>PubMed

29: Debaugnies F, Busson L, Ferster A, Lewalle P, Azzi N, Aoun M, Verhaegen G, Mahadeb B, de Marchin J, Vandenberg O, Hallin M. Detection of Herpesviridae in whole blood by multiplex PCR DNA-based microarray analysis after hematopoietic stem cell transplantation. J Clin Microbiol. 2014 Jul;52(7):2552-6. doi: 10.1128/JCM.00061-14. Epub 2014 May 14.
>PubMed

30: Noris P, Schlegel N, Klersy C, Heller PG, Civaschi E, Pujol-Moix N, Fabris F, Favier R, Gresele P, Latger-Cannard V, Cuker A, Nurden P, Greinacher A, Cattaneo M, De Candia E, Pecci A, Hurtaud-Roux MF, Glembotsky AC, Muñiz-Diaz E, Randi ML, Trillot N, Bury L, Lecompte T, Marconi C, Savoia A, Balduini CL, Bayart S, Bauters A, Benabdallah-Guedira S, Boehlen F, Borg JY, Bottega R, Bussel J, De Rocco D, de Maistre E, Faleschini M, Falcinelli E, Ferrari S, Ferster A, Fierro T, Fleury D, Fontana P, James C, Lanza F, Le Cam Duchez V, Loffredo G, Magini P, Martin-Coignard D, Menard F, Mercier S, Mezzasoma A, Minuz P, Nichele I, Notarangelo LD, Pippucci T, Podda GM, Pouymayou C, Rigouzzo A, Royer B, Sie P, Siguret V, Trichet C, Tucci A, Saposnik B, Veneri D; European Hematology Association – Scientific Working Group on Thrombocytopenias and Platelet Function Disorders. Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. Haematologica. 2014 Aug;99(8):1387-94. doi: 10.3324/haematol.2014.105924. Epub 2014 Apr 24.
>PubMed

31: Domenech C, Suciu S, De Moerloose B, Mazingue F, Plat G, Ferster A, Uyttebroeck A, Sirvent N, Lutz P, Yakouben K, Munzer M, Röhrlich P, Plantaz D, Millot F, Philippet P, Dastugue N, Girard S, Cavé H, Benoit Y, Bertrandfor Y; Children's Leukemia Group (CLG) of European Organisation for Research and Treatment of Cancer (EORTC). Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial. Haematologica. 2014 Jul;99(7):1220-7. doi: 10.3324/haematol.2014.103507. Epub 2014 Apr 11.
>PubMed

32: Dedeken L, Lê PQ, Azzi N, Brachet C, Heijmans C, Huybrechts S, Devalck C, Rozen L, Ngalula M, Ferster A. Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients. Br J Haematol. 2014 May;165(3):402-8. doi: 10.1111/bjh.12737. Epub 2014 Jan 16.
>PubMed

33: Tuerlinckx D, Florkin B, Ferster A, De Schutter I, Chantrain C, Haerynck F, Philippet P, Strengers P, Laub R. Pneumococcal antibody levels in children with PID receiving immunoglobulin. Pediatrics. 2014 Jan;133(1):e154-62. doi: 10.1542/peds.2013-1155. Epub 2013 Dec 23.
>PubMed

34: Rozen L, Huybrechts S, Dedeken L, Heijmans C, Dessars B, Heimann P, Lambert F, Noubouossie DF, Ferster A, Demulder A. Transient leukemia in a newborn without Down syndrome: case report and review of the literature. Eur J Pediatr. 2014 Dec;173(12):1643-7. doi: 10.1007/s00431-013-2163-8. Epub 2013 Nov 20. Review.
>PubMed

35: Clappier E, Auclerc MF, Rapion J, Bakkus M, Caye A, Khemiri A, Giroux C, Hernandez L, Kabongo E, Savola S, Leblanc T, Yakouben K, Plat G, Costa V, Ferster A, Girard S, Fenneteau O, Cayuela JM, Sigaux F, Dastugue N, Suciu S, Benoit Y, Bertrand Y, Soulier J, Cavé H. An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. Leukemia. 2014 Jan;28(1):70-7. doi: 10.1038/leu.2013.277. Epub 2013 Sep 25.
>PubMed

36: Noubouossie DC, Lê PQ, Rozen L, Ziereisen F, Willems D, Demulder A, Ferster A. Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial Doppler velocity, and hydroxyurea treatment. Eur J Haematol. 2013 Jul;91(1):46-54. doi: 10.1111/ejh.12113. Epub 2013 Apr 17.
>PubMed

37: Huybrechts S, De Laet C, Bontems P, Rooze S, Souayah H, Sznajer Y, Sturiale L, Garozzo D, Matthijs G, Ferster A, Jaeken J, Goyens P. Deficiency of Subunit 6 of the Conserved Oligomeric Golgi Complex (COG6-CDG): Second Patient, Different Phenotype. JIMD Rep. 2012;4:103-8. doi: 10.1007/8904_2011_79. Epub 2011 Nov 2.
>PubMed

38: Rodríguez A, Kouegnigan L, Ferster A, Cotton F, Duez P. Two assays to evaluate potential genotoxic effects of hydroxyurea in sickle cell disease patients. Hemoglobin. 2012;36(6):545-54. doi: 10.3109/03630269.2012.725688. Epub 2012 Oct 24.
>PubMed

39: Bertholdt S, Lê PQ, Heijmans C, Huybrechts S, Dedeken L, Devalck C, Schifflers S, Ferster A. [Respiratory complications of sickle cell anemia in children: the acute chest syndrome]. Rev Med Brux. 2012 May-Jun;33(3):138-44. French.
>PubMed

40: Noubouossie DC, Lê PQ, Rozen L, Debaugnies F, Ferster A, Demulder A. Evaluation of the procoagulant activity of endogenous phospholipids in the platelet-free plasma of children with sickle cell disease using functional assays. Thromb Res. 2012 Aug;130(2):259-64. doi: 10.1016/j.thromres.2011.10.016. Epub 2011 Nov 12.
>PubMed

41: Noubouossie DF, Lê PQ, Corazza F, Debaugnies F, Rozen L, Ferster A, Demulder A. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children. Am J Hematol. 2012 Feb;87(2):145-9. doi: 10.1002/ajh.22206. Epub 2011 Nov 4.
>PubMed

42: Quentin C, Huybrechts S, Rozen L, De Laet C, Demulder A, Ferster A. Vitamin B12 deficiency in a 9-month-old boy. Eur J Pediatr. 2012 Jan;171(1):193-5. doi: 10.1007/s00431-011-1577-4. Epub 2011 Sep 21.
>PubMed

43: Filippin L, Debaugnies F, Noubouossié D, Lê PQ, Ferster A, Demulder A. [Thrombin generation test: establishment of reference values according to age and tissue factor concentration is essential before implementation into the laboratory]. Rev Med Brux. 2011 Mar-Apr;32(2):69-73. French.
>PubMed

44: de Greef JC, Wang J, Balog J, den Dunnen JT, Frants RR, Straasheijm KR, Aytekin C, van der Burg M, Duprez L, Ferster A, Gennery AR, Gimelli G, Reisli I, Schuetz C, Schulz A, Smeets DFCM, Sznajer Y, Wijmenga C, van Eggermond MC, van Ostaijen-Ten Dam MM, Lankester AC, van Tol MJD, van den Elsen PJ, Weemaes CM, van der Maarel SM. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am J Hum Genet. 2011 Jun 10;88(6):796-804. doi: 10.1016/j.ajhg.2011.04.018. Epub 2011 May 19.
>PubMed

45: Bizumukama L, Ferster A, Gulbis B, Kumps A, Cotton F. Effects of disodium cromoglycate on cationic exchange of deoxygenated sickle cells. Eur J Pharmacol. 2011 Aug 31;665(1-3):13-8. doi: 10.1016/j.ejphar.2011.05.007. Epub 2011 May 11.
>PubMed

46: Lê PQ, Ferster A, Cotton F, Vertongen F, Vermylen C, Vanderfaeillie A, Dedeken L, Heijmans C, Ketelslegers O, Dresse MF, Gulbis B. Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management. Med Trop (Mars). 2010 Dec;70(5-6):467-70.
>PubMed

47: Renard M, Suciu S, Bertrand Y, Uyttebroeck A, Ferster A, van der Werff Ten Bosch J, Mazingue F, Plouvier E, Robert A, Boutard P, Millot F, Munzer M, Mechinaud F, Lescoeur B, Baila L, Vandecruys E, Benoit Y, Philippet P; EORTC Children Leukaemia Group (CLG). Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours. Pediatr Blood Cancer. 2011 Jul 15;57(1):119-25. doi: 10.1002/pbc.23083. Epub 2011 Mar 15.
>PubMed

48: Boudart J, Fink W, Theunis A, Dangoisse C, Ferster A, André J. [Granulomatous skin disease in an immunocompromised child]. Ann Dermatol Venereol. 2011 Jan;138(1):38-41. doi: 10.1016/j.annder.2010.09.016. Epub 2010 Nov 5. French.
>PubMed

49: Van Saen D, Goossens E, Bourgain C, Ferster A, Tournaye H. Meiotic activity in orthotopic xenografts derived from human postpubertal testicular tissue. Hum Reprod. 2011 Feb;26(2):282-93. doi: 10.1093/humrep/deq321. Epub 2010 Nov 30.
>PubMed

50: Kolivras A, Theunis A, Ferster A, Lipsker D, Sass U, Dussart A, André J. Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement. J Cutan Pathol. 2011 Feb;38(2):202-8. doi: 10.1111/j.1600-0560.2010.01638.x. Epub 2010 Nov 10.
>PubMed

51: de Montalembert M, Ferster A, Colombatti R, Rees DC, Gulbis B; European Network for Rare and Congenital Anaemias. ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children. Am J Hematol. 2011 Jan;86(1):72-5. doi: 10.1002/ajh.21865.
>PubMed

52: Ries F, Ferster A, Rieux-Laucat F, Biwer A, Dicato M. Autoimmune lymphoproliferative syndrome (ALPS). Case report and family history. Bull Soc Sci Med Grand Duche Luxemb. 2010;(2):271-8.
>PubMed

53: De Moerloose B, Suciu S, Bertrand Y, Mazingue F, Robert A, Uyttebroeck A, Yakouben K, Ferster A, Margueritte G, Lutz P, Munzer M, Sirvent N, Norton L, Boutard P, Plantaz D, Millot F, Philippet P, Baila L, Benoit Y, Otten J; Children's Leukemia Group of the European Organisation for Research and Treatment of Cancer (EORTC). Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951. Blood. 2010 Jul 8;116(1):36-44. doi: 10.1182/blood-2009-10-247965. Epub 2010 Apr 20.
>PubMed

54: Neven B, Marvillet I, Terrada C, Ferster A, Boddaert N, Couloignier V, Pinto G, Pagnier A, Bodemer C, Bodaghi B, Tardieu M, Prieur AM, Quartier P. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum. 2010 Jan;62(1):258-67. doi: 10.1002/art.25057.
>PubMed

55: Casimir GJ, Mulier S, Hanssens L, Knoop C, Ferster A, Hofman B, Duchateau J. Chronic inflammatory diseases in children are more severe in girls. Shock. 2010 Jul;34(1):23-6. doi: 10.1097/SHK.0b013e3181ce2c3d.
>PubMed

56: Scaillon M, Van Biervliet S, Bontems P, Dorchy H, Hanssens L, Ferster A, Segers V, Cadranel S. Severe gastritis in an insulin-dependent child with an IPEX syndrome. J Pediatr Gastroenterol Nutr. 2009 Sep;49(3):368-70. doi: 10.1097/MPG.0b013e3181a159de.
>PubMed

57: Bizumukama L, Ferster A, Gulbis B, Kumps A, Cotton F. In vitro inhibitory effects of disodium cromoglycate on ionic transports involved in sickle cell dehydration. Pharmacology. 2009;83(5):318-22. doi: 10.1159/000215598. Epub 2009 Apr 25.
>PubMed

58: Kettani T, Cotton F, Gulbis B, Ferster A, Kumps A. Plasma hydroxyurea determined by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Feb 1;877(4):446-50. doi: 10.1016/j.jchromb.2008.12.048. Epub 2008 Dec 25.
>PubMed

59: Gulbis B, Cotton F, Ferster A, Ketelslegers O, Dresse MF, Rongé-Collard E, Minon JM, Lé PQ, Vertongen F. Neonatal haemoglobinopathy screening in Belgium. J Clin Pathol. 2009 Jan;62(1):49-52. doi: 10.1136/jcp.2008.060517.
>PubMed

60: Gulbis B, Ferster A, Vermylen C, Dresse MF, Vanderfaeillie A, Delannoy A, Labarque V, Philippet P, Kentos A, Sztern B, Deprijck B, Vertongen F; Red Blood Cell Disorders Subcommittee of the Belgian Haematological Society. An estimation of the incidence and demographic picture of the major hemoglobinopathies in Belgium (from a confidential inquiry). Hemoglobin. 2008;32(3):279-85. doi: 10.1080/03630260802004400.
>PubMed

61: Uyttebroeck A, Suciu S, Laureys G, Robert A, Pacquement H, Ferster A, Marguerite G, Mazingue F, Renard M, Lutz P, Rialland X, Mechinaud F, Cavé H, Baila L, Bertrand Y; Children's Leukaemia Group (CLG) of the European Organisation for Research and Treatment of Cancer (EORTC). Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial. Eur J Cancer. 2008 Apr;44(6):840-6. doi: 10.1016/j.ejca.2008.02.011. Epub 2008 Mar 14.
>PubMed

62: Cappellini MD, Bejaoui M, Agaoglu L, Porter J, Coates T, Jeng M, Lai ME, Mangiagli A, Strauss G, Girot R, Watman N, Ferster A, Loggetto S, Abish S, Cario H, Zoumbos N, Vichinsky E, Opitz H, Ressayre-Djaffer C, Abetz L, Rofail D, Baladi JF. Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. Clin Ther. 2007 May;29(5):909-917. doi: 10.1016/j.clinthera.2007.05.007.
>PubMed

63: Pieters R, Schrappe M, De Lorenzo P, Hann I, De Rossi G, Felice M, Hovi L, LeBlanc T, Szczepanski T, Ferster A, Janka G, Rubnitz J, Silverman L, Stary J, Campbell M, Li CK, Mann G, Suppiah R, Biondi A, Vora A, Valsecchi MG. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007 Jul 21;370(9583):240-250. doi: 10.1016/S0140-6736(07)61126-X.
>PubMed

64: Brachet C, Heinrichs C, Tenoutasse S, Devalck C, Azzi N, Ferster A. Children with sickle cell disease: growth and gonadal function after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2007 Jul;29(7):445-50.
>PubMed

65: Gulbis B, Ferster A, Cotton F, Lebouchard MP, Cochaux P, Vertongen F. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels. J Med Screen. 2006;13(2):76-8.
>PubMed

66: Klein A, Brachet C, Azzi N, Ferster A. [Hematopoietic stem cell transplantation for severe sickle cell disease]. Rev Med Brux. 2005;26 Spec no:Sp23-5. Review. French.
>PubMed

67: Névessignsky MT, Ferster A. Haematopoietic stem cell transplantation for severe autoimmune diseases: new perspectives. Nephrol Dial Transplant. 2006 May;21(5):1154-7. Epub 2006 Jan 23.
>PubMed

68: Ziereisen F, Dan B, Azzi N, Ferster A, Damry N, Christophe C. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features. Pediatr Radiol. 2006 Mar;36(3):205-12. Epub 2005 Dec 21.
>PubMed

69: Corazza F, Hermans C, D'Hondt S, Ferster A, Kentos A, Benoît Y, Sariban E. Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia. Blood. 2006 Mar 15;107(6):2525-30. Epub 2005 Nov 29.
>PubMed

70: Gulbis B, Ferster A, Kentos A, N'Gay Munungi D, Cotton F, Rongé E, Dresse MF, Bradstreet C, Cochaux P, Vertongen F. [Sickle cell disease: exotic disease or a Belgian public health problem?]. Rev Med Brux. 2005 Sep;26(4):S309-13. Review. French.
>PubMed

71: Saussez S, Mahillon V, Haller A, Levy J, Ferster A, Dargent JL. Clinically unsuspected tonsillar sarcoidosis in a child revealed by routine histologic examination. Int J Pediatr Otorhinolaryngol. 2006 Jan;70(1):155-8. Epub 2005 Jul 18.
>PubMed

72: van der Werff Ten Bosch J, Suciu S, Thyss A, Bertrand Y, Norton L, Mazingue F, Uyttebroeck A, Lutz P, Robert A, Boutard P, Ferster A, Plouvier E, Maes P, Munzer M, Plantaz D, Dresse MF, Philippet P, Sirvent N, Waterkeyn C, Vilmer E, Philippe N, Otten J. Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG. Leukemia. 2005 May;19(5):721-6.
>PubMed

73: Laugel V, Escande B, Entz-Werle N, Mazingue F, Ferster A, Bertrand Y, Missud F, Lutz P. [Severe acute pancreatitis in children receiving asparaginase: multicenter retrospective study]. Arch Pediatr. 2005 Jan;12(1):34-41. French.
>PubMed

74: Gulbis B, Haberman D, Dufour D, Christophe C, Vermylen C, Kagambega F, Corazza F, Devalck C, Dresse MF, Hunninck K, Klein A, Le PQ, Loop M, Maes P, Philippet P, Sariban E, Van Geet C, Ferster A. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience. Blood. 2005 Apr 1;105(7):2685-90. Epub 2004 Dec 16.
>PubMed

75: Brachet C, Azzi N, Demulder A, Devalck C, Gourdin A, Gulbis B, Klein A, Le PQ, Loop M, Sariban E, Ferster A. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome. Bone Marrow Transplant. 2004 Apr;33(8):799-803.
>PubMed

76: Loop M, Ferster A, Corazza F, Alhenc-Gelas M, Demulder A. Late onset of clinical symptoms and recurrent ecchymotic skin lesions in a 12-year-old girl with a severe double heterozygous protein C deficiency. J Pediatr Hematol Oncol. 2004 Jan;26(1):2-4.
>PubMed

77: Corazza F, Hermans C, Ferster A, Fondu P, Demulder A, Sariban E. Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children. Pediatr Res. 2004 Jan;55(1):152-8. Epub 2003 Oct 15.
>PubMed

78: Dargent JL, Ferster A, Andry G, Devriendt D, Lemort M, Lespagnard L, Verhest A. Marginal zone B-cell lymphoma of the sinonasal tract in an eleven-year-old girl. Med Pediatr Oncol. 2003 Jun;40(6):393-5.
>PubMed

79: Servais L, Ferster A, Demulder A, Sékhara T, Mewasingh LD, Christophe C, Dan B. [Chronic subdural hematoma and extramedullary erythropoiesis in an infant]. Rev Neurol (Paris). 2003 Feb;159(2):206-8. French.
>PubMed

80: Dhooge C, De Moerloose B, Laureys G, Ferster A, De Bacquer D, Philippe J, Leroy J, Benoit Y. Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: results of a long-term prospective study. Leuk Lymphoma. 2002 Feb;43(2):309-14.
>PubMed

81: van der Werff Ten Bosch J, Schotte P, Ferster A, Azzi N, Boehler T, Laurey G, Arola M, Demanet C, Beyaert R, Thielemans K, Otten J. Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations. Br J Haematol. 2002 Apr;117(1):176-88.
>PubMed

82: Otten J, Philippe N, Suciu S, Béhar C, Babin-Boilletot A, Thyss A, Ferster A, Vilmer E; EORTC Children Leukemia Group. The Children Leukemia Group: 30 years of research and achievements. Eur J Cancer. 2002 Mar;38 Suppl 4:S44-9.
>PubMed

83: Gulbis B, Cotton F, Hansen V, Ferster A, Toppet M, Cochaux P, Parma J, Vassart G, Fondu P, Vertongen F. [Prevention of hemoglobinopathies in Brussels: a necessity?]. Rev Med Brux. 2001 Jun;22(3):133-40. Review. French.
>PubMed

84: Farber CM, Benoit Y, Boven K, De Baets F, Ferster A, Hoyoux C, Mascart F, Otten J, Philippet P, Van Lierde S, Van Vooren JP, Vermylen C. [Immune deficiencies: diagnosis, management, some perspectives]. Rev Med Brux. 2001 Apr;22(2):73-82. Review. French.
>PubMed

85: Ferster A, Tahriri P, Vermylen C, Sturbois G, Corazza F, Fondu P, Devalck C, Dresse MF, Feremans W, Hunninck K, Toppet M, Philippet P, Van Geet C, Sariban E. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood. 2001 Jun 1;97(11):3628-32.
>PubMed

86: Damry N, Hottat N, Azzi N, Ferster A, Avni F. Unusual findings in two cases of Langerhans' cell histiocytosis. Pediatr Radiol. 2000 Mar;30(3):196-9.
>PubMed

87: Lambert J, Naeyaert JM, De Paepe A, Van Coster R, Ferster A, Song M, Messiaen L. arg-cys substitution at codon 1246 of the human myosin Va gene is not associated with Griscelli syndrome. J Invest Dermatol. 2000 Apr;114(4):731-3.
>PubMed

88: Madani A, Christophe C, Ferster A, Dan B. Peri-optic nerve infiltration during leukaemic relapse: MRI diagnosis. Pediatr Radiol. 2000 Jan;30(1):30-2.
>PubMed

89: Klein A, Corazza F, Demulder A, Van Beers D, Ferster A. Recurrent viral associated hemophagocytic syndrome in a child with Langerhans cell histiocytosis. J Pediatr Hematol Oncol. 1999 Nov-Dec;21(6):554-6.
>PubMed

90: Christophe C, Azzi N, Bouché B, Dan B, Levivier M, Ferster A. Magnetic resonance imaging and angiography in cerebral fungal vasculitis. Neuropediatrics. 1999 Aug;30(4):218-20.
>PubMed

91: Lejeune M, Cantinieaux B, Harag S, Ferster A, Devalck C, Sariban E. Defective functional activity and accelerated apoptosis in neutrophils from children with cancer are differentially corrected by granulocyte and granulocyte-macrophage colony stimulating factors in vitro. Br J Haematol. 1999 Sep;106(3):756-61.
>PubMed

92: Dresse MF, Boogaerts M, Vermylen C, Noens L, Ferrant A, Schots R, Doyen C, Bron D, Berneman Z, Ferster A, Benoit Y, Demuynck H, Beguin Y. The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor. Haematologica. 1999 Jul;84(7):637-42.
>PubMed

93: Dhooge C, De Moerloose B, Laureys G, Kint J, Ferster A, De Bacquer D, Philippe J, Benoit Y. P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study. Br J Haematol. 1999 Jun;105(3):676-83.
>PubMed

94: Fall AB, Vanhaelen-Fastré R, Vanhaelen M, Lo I, Toppet M, Ferster A, Fondu P. In vitro antisickling activity of a rearranged limonoid isolated from Khaya senegalensis. Planta Med. 1999 Apr;65(3):209-12.
>PubMed

95: Versteegh C, Avni F, Cuvelier P, Ferster A. [Persistence of pulmonary lesions in a 6-year-old boy with type I Gaucher's disease treated by alglucerase since the age of 20 months]. Arch Pediatr. 1998 Dec;5(12):1341-3. French.
>PubMed

96: Fall AB, Toppet M, Ferster A, Fondu P, Vanhaelen-Fastré R, Vanhaelen M. In vitro antisickling activity of cromolyn sodium. Br J Haematol. 1998 Dec;103(4):957-9.
>PubMed

97: Lejeune M, Ferster A, Cantinieaux B, Sariban E. Prolonged but reversible neutrophil dysfunctions differentially sensitive to granulocyte colony-stimulating factor in children with acute lymphoblastic leukaemia. Br J Haematol. 1998 Sep;102(5):1284-91.
>PubMed

98: Corazza F, Beguin Y, Bergmann P, André M, Ferster A, Devalck C, Fondu P, Buyse M, Sariban E. Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production. Blood. 1998 Sep 1;92(5):1793-8.
>PubMed

99: Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A, Zenebergh A, Maes P, Dhooge C, Benoit Y, Beguin Y, Dresse MF, Sariban E. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant. 1998 Jul;22(1):1-6.
>PubMed

100: Tshilolo L, Gulbis B, Barlow P, Damis E, Denis-Song R, Ferster A, Haumont D, Vanderpas JB, Pardou A, Schwers J, Vokaer A, Vertongen F. [Neonatal screening for hemoglobinopathies in the Brussels region]. Rev Med Brux. 1997 Apr;18(2):70-3. French.
>PubMed

101: Gourdin A, Demulder A, Ferster A, Fondu P. [Value of in vitro study of osteoclast precursors in the case of severe infantile osteopetrosis treated by bone marrow graft]. Arch Pediatr. 1997 Apr;4(4):335-8. French.
>PubMed

102: Lejeune M, Sariban E, Cantinieaux B, Ferster A, Devalck C, Fondu P. Defective polymorphonuclear leukocyte functions in children receiving chemotherapy for cancer are partially restored by recombinant human granulocyte colony-stimulating factor in vitro. J Infect Dis. 1996 Oct;174(4):800-5.
>PubMed

103: Ferster A, Vermylen C, Cornu G, Buyse M, Corazza F, Devalck C, Fondu P, Toppet M, Sariban E. Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood. 1996 Sep 15;88(6):1960-4.
>PubMed

104: de Laet C, Casimir G, Duchâteau J, Vamos E, Devalck C, Sariban E, Ferster A. [Leukemia lymphoma T-cell as first manifestation of ataxia-telangiectasia]. Arch Pediatr. 1996 Jul;3(7):681-4. French.
>PubMed

105: Lejeune M, Sariban E, Cantinieaux B, Ferster A, Devalck C, Fondu P. Granulocyte functions in children with cancer are differentially sensitive to the toxic effect of chemotherapy. Pediatr Res. 1996 May;39(5):835-42.
>PubMed

106: Renneboog B, Hansen V, Heimann P, De Mulder A, Jannsen F, Ferster A. Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7. Br J Haematol. 1996 Mar;92(3):696-8.
>PubMed

107: De Wolf K, Ferster A, Sass U, André J, Stene JJ, Song M. Netherton's syndrome: a severe neonatal disease. A case report. Dermatology. 1996;192(4):400-2.
>PubMed

108: Ferster A, Corazza F, Vertongen F, Bujan W, Devalck C, Fondu P, Cochaux P, Lambermont M, Khaladji Z, Sariban E. Transplanted sickle-cell disease patients with autologous bone marrow recovery after graft failure develop increased levels of fetal haemoglobin which corrects disease severity. Br J Haematol. 1995 Aug;90(4):804-8.
>PubMed

109: Ben Salah H, Crockaert F, Levy J, Ferster A, Devalck C, Sariban E. [Stomatococcus mucilaginosus meningitis in immunocompromised child]. Arch Pediatr. 1994 Sep;1(9):813-5. French.
>PubMed

110: Ferster A, Bujan W, Mouraux T, Devalck C, Heimann P, Sariban E. Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation. Bone Marrow Transplant. 1994 Aug;14(2):331-2.
>PubMed

111: Heimann P, Vamos E, Ferster A, Sariban E. Granulocytic sarcoma showing chromosomal changes other than the t(8;21). Cancer Genet Cytogenet. 1994 May;74(1):59-61.
>PubMed

112: Ferster A, Bertrand Y, Benoit Y, Boilletot A, Behar C, Margueritte G, Thyss A, Robert A, Mazingue F, Souillet G, et al. Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-Childhood Leukaemia Cooperative Group. Br J Haematol. 1994 Feb;86(2):284-90.
>PubMed

113: Devalck C, Tempels D, Ferster A, De Laet MH, Bujan W, Heiman P, Sariban E. Long-term disease-free survival in a child with refractory metastatic malignant germ cell tumor treated by high-dose chemotherapy with autologous bone marrow rescues. Med Pediatr Oncol. 1994;22(3):208-10.
>PubMed

114: Ferster A, Corazza F, Heimann P, Dehou MF, De Busscher C, Devalck C, Sariban E, Vamos E. Anaplastic large cell lymphoma of true histiocytic origin in an infant: unusual clinical, hematological, and cytogenetic features. Med Pediatr Oncol. 1994;22(2):147-52.
>PubMed

115: Ouchiha M, Ferster A, Heiman P, Bujan W, Perlmutter N, Devalck C, Sariban E. [Granulocytic sarcoma with mediastinal involvement]. Arch Fr Pediatr. 1993 Nov;50(9):775-8. French.
>PubMed

116: Ferster A, Bujan W, Corazza F, Devalck C, Fondu P, Toppet M, Verhas M, Sariban E. Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia. Blood. 1993 Feb 15;81(4):1102-5.
>PubMed

117: Ferster A, Capouet V, Deville A, Fondu P, Corazza F. Cardiac surgery with extracorporeal circulation in severe factor VII deficiency. Haemostasis. 1993;23(1):65-8.
>PubMed

118: Schandené L, Ferster A, Mascart-Lemone F, Crusiaux A, Gérard C, Marchant A, Lybin M, Velu T, Sariban E, Goldman M. T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol. 1993 Jan;23(1):56-60.
>PubMed

119: Vermylen C, Cornu G, Ferster A, Ninane J, Sariban E. Bone marrow transplantation in sickle cell disease: the Belgian experience. Bone Marrow Transplant. 1993;12 Suppl 1:116-7.
>PubMed

120: Schandené L, Mascart-Lemone F, Ferster A, Gérard C, Lybin M, Sariban E, Velu T, Goldman M. Helper T cell dysfunctions in a patient with Omenn's syndrome: modulation by IFN-gamma therapy. Immunodeficiency. 1993;4(1-4):89-91.
>PubMed

121: Ferster A, Glinoër D, Van Vliet G, Otten J. Thyroid function during L-asparaginase therapy in children with acute lymphoblastic leukemia: difference between induction and late intensification. Am J Pediatr Hematol Oncol. 1992 Aug;14(3):192-6.
>PubMed

122: Bujan W, Ferster A, Devalck C, Vamos E, Mascart F, Denis R, Azzi N, Vergauwen P, Sariban E. [Bone marrow graft in hereditary diseases]. Rev Med Brux. 1992 Jun;13(6):207-11. French.
>PubMed

123: Ferster A, Azzi N, Bujan W, Devalck C, Fondu P, Nafa S, Toppet M, Sariban E. [Indications for bone marrow graft in severe hemoglobinopathies]. Rev Med Brux. 1992 Jun;13(6):213-7. French.
>PubMed

124: Devalck C, Ferster A, De Laet MH, Nafa S, Bujan W, Azzi N, Ben Salah H, Corrazza F, Vergauwen P, Sariban E. [Autologous bone marrow graft in solid tumors in childhood]. Rev Med Brux. 1992 Jun;13(6):201-6. Review. French.
>PubMed

125: Andre M, Ferster A, Toppet M, Fondu P, Dratwa M, Bergmann P. Performance of an immunoradiometric assay of erythropoietin and results for specimens from anemic and polycythemic patients. Clin Chem. 1992 May;38(5):758-63.
>PubMed

126: Bujan W, Ferster A, Azzi N, Devalck C, Leriche A, Sariban E. Use of recombinant human granulocyte colony stimulating factor in reticular dysgenesis. Br J Haematol. 1992 May;81(1):128-30.
>PubMed

127: Ferster A, De Valck C, Azzi N, Fondu P, Toppet M, Sariban E. Bone marrow transplantation for severe sickle cell anaemia. Br J Haematol. 1992 Jan;80(1):102-5.
>PubMed

128: Bieva C, Martiat P, Ferster A, Sariban E, Kedar A, Erdos G, Bron D, Debusscher L, Stryckmans P. Autologous bone marrow transplantation for acute leukemia using ferromagnetic microparticles and monoclonal antibody-purged marrows: demonstration of effectiveness by polymerase chain reaction. Prog Clin Biol Res. 1992;377:197-204.
>PubMed

129: André M, Bergmann P, Ferster A, Toppet M, Fondu P. Serum immunoreactive erythropoietin level: a new parameter for monitoring transfusion management of thalassaemia. Nouv Rev Fr Hematol. 1991;33(4):299-302.
>PubMed

130: Cantinieaux B, Hariga C, Ferster A, Toppet M, Fondu P. Desferrioxamine improves neutrophil phagocytosis in thalassemia major. Am J Hematol. 1990 Sep;35(1):13-7.
>PubMed

131: Przedborski S, Ferster A, Goldman S, Wolter R, Song M, Tonnesen T, Pollitt RJ, Vamos E. Trichothiodystrophy, mental retardation, short stature, ataxia, and gonadal dysfunction in three Moroccan siblings. Am J Med Genet. 1990 Apr;35(4):566-73.
>PubMed

132: Jacobs A, Delree M, Desprechins B, Otten J, Ferster A, Jonckheer MH, Mertens J, Ham HR, Piepsz A. Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience. Pediatr Radiol. 1990;20(3):157-9.
>PubMed

133: Courtois P, Ferster A, Fondu P, Mandelbaum IM. Protein kinase C deficiency in juvenile chronic myeloid leukemia: a case report. Nouv Rev Fr Hematol. 1989;31(4):317-9.
>PubMed

134: Ninane J, Baurain R, de Kraker J, Ferster A, Trouet A, Cornu G. Alkylating activity in serum, urine, and CSF following high-dose ifosfamide in children. Cancer Chemother Pharmacol. 1989;24 Suppl 1:S2-6; discussion S7.
>PubMed

135: Ferster A, Schots R, Maurus R, Otten J. Neuroblastoma today. Biomed Pharmacother. 1988;42(4):247-55. Review.
>PubMed

136: Cantinieaux B, Hariga C, Ferster A, De Maertelaere E, Toppet M, Fondu P. Neutrophil dysfunctions in thalassaemia major: the role of cell iron overload. Eur J Haematol. 1987 Jul;39(1):28-34.
>PubMed

137: Toppet M, Ferster A, Elmer C, Jonckheer T, Levy J, Sprecher S, Fondu P. Haemophilia and HIV infection in a Belgian center. Acta Clin Belg. 1987;42(5):394-5.
>PubMed

!Data extracted directly from PubMed and filtered to reduce the risk of homonymy. You can remove the "QFCUH" filter to enlarge results.

>>More about Prof. Alice FERSTER.